Literature DB >> 32437734

FOX transcription factor family in hepatocellular carcinoma.

Zhongqin Gong1, Jianqing Yu1, Shucai Yang2, Paul B S Lai3, George G Chen4.   

Abstract

The pathogenesis of hepatocellular carcinoma (HCC) is a multistep process, involving the progressive accumulation of molecular alterations and transcriptomic alterations. The Forkhead-box (FOX) transcription factor family is characterized by its unique DNA binding domain (FKH or winged-helix domain). Human FOX family consists of about 17 subfamilies, at least 43 members. Some of them are liver-enriched transcription factors, suggesting that they may play a crucial role in the development or/and functions of the liver. Dysregulation of FOX transcription factors may contribute to the pathogenesis of HCC because they can activate or suppress the expression of various tumor-related molecules, and pinpoint different molecular and cellular events. Here we summarized, analyzed and discussed the status and the functions of the human FOX family of transcription factors in HCC, aiming to help the further development of them as potential therapeutic targets or/and diagnostic/prognostic markers for HCC.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Forkhead-box; Hepatocellular carcinoma; Liver-enriched; Transcription factors

Year:  2020        PMID: 32437734     DOI: 10.1016/j.bbcan.2020.188376

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  6 in total

1.  Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.

Authors:  Jin Li; Tingyuan Yan; Xiang Wu; Xueping Ke; Xin Li; Yumin Zhu; Jianrong Yang; Zhongwu Li
Journal:  BMC Cancer       Date:  2021-11-12       Impact factor: 4.430

2.  Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy.

Authors:  Yunqiang Liu; Mengjun Tu; Lingling Wang
Journal:  Int J Gen Med       Date:  2022-02-25

Review 3.  Regulation and roles of FOXK2 in cancer.

Authors:  Yuanyuan Kang; Kexin Zhang; Lixue Sun; Ying Zhang
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

4.  Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma.

Authors:  Dan-Dan Zhang; Yi Shi; Ji-Bin Liu; Xiao-Li Yang; Rui Xin; Hui-Min Wang; Pei-Yao Wang; Cheng-You Jia; Wen-Jie Zhang; Yu-Shui Ma; Da Fu
Journal:  Mol Ther Nucleic Acids       Date:  2021-05-01       Impact factor: 8.886

5.  Development of a genetically modified hepatoma cell line with heat-inducible high liver function.

Authors:  Hiroyuki Kitano; Yuki Nagae; Yoshinori Kawabe; Akira Ito; Masamichi Kamihira
Journal:  Cytotechnology       Date:  2021-02-24       Impact factor: 2.040

6.  MiR-466 Inhibits the Progression of Severe Hepatocellular Carcinoma via Regulating FMNL2-Mediated Activation of NF-κB and Wnt/β-Catenin Pathways.

Authors:  Jianwei Li; Su Yan
Journal:  J Oncol       Date:  2021-06-23       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.